Learn

1. The fundamental concepts and principles for utilising Real World Evidence (RWE) towards optimising Market Access.
2. The value RWE adds over RCTs over a product’s entire lifecycle.
3. The terminology used within the world of RWE, such as the exact difference between Real World Evidence and Real World Data (RWD).
4. Why RWE is important to regulators, payers, physicians and pharma and how to tailor the evidence to their specific needs.
5. The common sources of data available for RWE and how to assess the robustness of the data.
6. The critical success factors when developing a RWE study.
7. How to effectively incorporate RWE into product launch decisions.

Why You Should Attend

RWE is now a critical area of expertise in pharmaceutical companies, engaging various functions such as HEOR, Medical Affairs, R&D and Commercial. There are many challenges in the process of successfully implementing RWE. Executives participating in this open-enrollment course will contribute much more effectively in the cross-functional organisation that RWE requires.

The Content: The course covers the basics required to understand what RWE is, why it is important, who needs/uses it and how you can utilise it effectively to help your role. The content contains the recent developments on RWE, as well as real life case studies on how RWE can be used and potential challenges that can arise.

The Experts: Graham and Paul are experts in RWE and Market access. They frequently advise companies on how to optimise the clinical development and commercial launch of new products, utilising RWE to help achieve market access. Both are regular guest lectures at universities and business schools, as well as speaking at international events and conferences.

The Generating RWE for Optimising Market Access course is the only available public training course delivered by Dr. Paul Craddy & Dr. Graham Foxon on this topic.

Who Should Attend?

As the RWE function is embedded in different departments and evolving at a different pace across the pharmaceutical industry, this course will benefit the many executive profiles who need the basics and need a common understanding in order to work effectively with their experienced colleagues in RWE:

• Executives new to RWE
• Recently appointed members to RWE teams
• Pharma executives not currently working in RWE
• Therapy area leads or brand leads
• Market access leads
• R&D and commercial teams requiring an understanding of RWE

As this course is delivered by Dr. Paul Craddy & Dr. Graham Foxon from Remap Consulting, a leading pharma consultancy company, executives from other professional service agencies should request approval prior to registering for this course. Please contact Inge Cornelis, Director Commercial Communications, for more information (inge.cornelis@celforpharma.com, tel +32 (0)2 709 01 43).

Past Participants

Below is a non-exhaustive list of past participants who have benefited from attending this course.

Testimonials

Read All Testimonials From This Course

Dates & Locations

• 3 March 2021, live online

• 25 November 2021, in Brussels or Zurich, or live online

Hotel Booking Assistance

Having built a strong relationship with each hotel, CELforPharma has secured preferential room rates for our delegates who book their accommodation three weeks or more prior to the course. Upon your registration, we will help you make your hotel booking. For any assistance in this matter please do not hesitate to contact Sarah Nissen, Senior Programme Coordinator (sarah.nissen@celforpharma.com, tel +32 (0)2 709 01 46).

Included in the Registration Fee for the live online course​

• Access to an expert led course in real-time, using an interactive platform for break-out rooms, whiteboard exercises, polling, plenary discussions and chats
• Course material, which will be provided to you in both digital format (by email) and in hard copy (by post, so you can make notes during the course)
• Certificate of attendance signed by the expert and CELforPharma
• Flexible transfer option

Included in the Registration Fee​ for the face-to-face course

• Course Material (Digital & Print Versions)
• Coffee, Tea & Refreshments During the Course
• Lunch During the Course
• Certificate of Attendance Signed by the Experts
• Flexible Transfer Option
• Optimal Safety: Small Groups (16 max) and Spacious Seating

Group Discounts

Team discounts can be offered to 3 or more delegates from the same company.
Contact Inge Cornelis, Director Commercial Communications, (inge.cornelis@celforpharma.com) for more details.

How to Register

1. Click the "Register Here" button on this page.
2. Choose a course date, then fill out your personal details and company / invoicing details.
3. Choose to pay via bank transfer or by credit card.
4. Click "Confirm Registration". You will be sent an automatic email confirming your registration followed by a personal email containing an invoice and further payment instructions.

For assistance in registering, raising a PO or invoicing, please do not hesitate to contact Kealeigh Steel.
(email: kealeigh.steel@celforpharma.com or call: +32 2 709 01 45)

Transfer & Cancellation Policy

Flexible Transfer

• If a registrant cannot attend the scheduled course, he/she can avoid any cancellation charge by sending a suitable replacement participant.
• Alternatively, the registrant can transfer once at no extra cost, until 3 weeks prior to the event, to another course held before 31 December 2021.

Participant Cancellation

• Up to 6 weeks prior to the course: cancellation fee of € 400 per participant.
• Up to 5 weeks prior to the course: 25% of the invoiced registration fee.
• Up to 4 weeks prior to the course: 50% of the invoiced registration fee.
• Up to 3 weeks prior to the course: 75% of the invoiced registration fee.
• Fewer than 3 weeks or if no notification received: registrant liable to pay invoiced registration fee.
• If a registrant postpones his/her participation to a future course, and cancels again, no refund can be claimed for registration fees.